請用此 Handle URI 來引用此文件:
http://tdr.lib.ntu.edu.tw/jspui/handle/123456789/69926
完整後設資料紀錄
DC 欄位 | 值 | 語言 |
---|---|---|
dc.contributor.advisor | 劉興華(Shing-Hwa Liu) | |
dc.contributor.author | Szu-Ta Chen | en |
dc.contributor.author | 陳思達 | zh_TW |
dc.date.accessioned | 2021-06-17T03:34:26Z | - |
dc.date.available | 2021-12-31 | |
dc.date.copyright | 2018-02-22 | |
dc.date.issued | 2018 | |
dc.date.submitted | 2018-02-13 | |
dc.identifier.citation | 1 McColl KE. Clinical practice. Helicobacter pylori infection. N Engl J Med 2010;362(17):1597-604.
2 Bruce MG, Maaroos HI. Epidemiology of Helicobacter pylori infection. Helicobacter 2008;13 Suppl 1:1-6. 3 Weyermann M, Rothenbacher D, Brenner H. Acquisition of Helicobacter pylori infection in early childhood: independent contributions of infected mothers, fathers, and siblings. Am J Gastroenterol 2009;104(1):182-9. 4 O'Connor A, O'Morain CA, Ford AC. Population screening and treatment of Helicobacter pylori infection. Nat Rev Gastroenterol Hepatol 2017;14(4):230-40. 5 Yuan W, Li Y, Yang K, et al. Iron deficiency anemia in Helicobacter pylori infection: meta-analysis of randomized controlled trials. Scand J Gastroenterol 2010;45(6):665-76. 6 Qu XH, Huang XL, Xiong P, et al. Does Helicobacter pylori infection play a role in iron deficiency anemia? A meta-analysis. World J Gastroenterol 2010;16(7):886-96. 7 Vendt N, Kool P, Teesalu K, et al. Iron deficiency and Helicobacter pylori infection in children. Acta Paediatr 2011;100(9):1239-43. 8 Xia W, Zhang X, Wang J, et al. Survey of anaemia and Helicobacter pylori infection in adolescent girls in Suihua, China and enhancement of iron intervention effects by H. pylori eradication. Br J Nutr 2012;108(2):357-62. 9 Franceschi F, Zuccala G, Roccarina D, et al. Clinical effects of Helicobacter pylori outside the stomach. Nat Rev Gastroenterol Hepatol 2014;11(4):234-42. 10 Tan S, Noto JM, Romero-Gallo J, et al. Helicobacter pylori perturbs iron trafficking in the epithelium to grow on the cell surface. PLoS Pathog 2011;7(5):e1002050. 11 Babitt JL, Lin HY. Molecular mechanisms of hepcidin regulation: implications for the anemia of CKD. Am J Kidney Dis 2010;55(4):726-41. 12 Pietrangelo A. Hepcidin in human iron disorders: therapeutic implications. J Hepatol 2011;54(1):173-81. 13 Nemeth E, Rivera S, Gabayan V, et al. IL-6 mediates hypoferremia of inflammation by inducing the synthesis of the iron regulatory hormone hepcidin. J Clin Invest 2004;113(9):1271-6. 14 Sato Y, Yoneyama O, Azumaya M, et al. The relationship between iron deficiency in patients with Helicobacter pylori-infected nodular gastritis and the serum prohepcidin level. Helicobacter 2015;20(1):11-8. 15 Banatvala N, Mayo K, Megraud F, et al. The cohort effect and Helicobacter pylori. J Infect Dis 1993;168(1):219-21. 16 Malaty HM, El-Kasabany A, Graham DY, et al. Age at acquisition of Helicobacter pylori infection: a follow-up study from infancy to adulthood. Lancet 2002;359(9310):931-5. 17 Czinn SJ. Helicobacter pylori infection: detection, investigation, and management. J Pediatr 2005;146(3 Suppl):S21-6. 18 Goodman KJ, Correa P. Transmission of Helicobacter pylori among siblings. Lancet 2000;355(9201):358-62. 19 Wilson KT, Crabtree JE. Immunology of Helicobacter pylori: insights into the failure of the immune response and perspectives on vaccine studies. Gastroenterology 2007;133(1):288-308. 20 Haeberle HA, Kubin M, Bamford KB, et al. Differential stimulation of interleukin-12 (IL-12) and IL-10 by live and killed Helicobacter pylori in vitro and association of IL-12 production with gamma interferon-producing T cells in the human gastric mucosa. Infect Immun 1997;65(10):4229-35. 21 Pathak SK, Basu S, Bhattacharyya A, et al. TLR4-dependent NF-kappaB activation and mitogen- and stress-activated protein kinase 1-triggered phosphorylation events are central to Helicobacter pylori peptidyl prolyl cis-, trans-isomerase (HP0175)-mediated induction of IL-6 release from macrophages. J Immunol 2006;177(11):7950-8. 22 Amieva M, Peek RM, Jr. Pathobiology of Helicobacter pylori-Induced Gastric Cancer. Gastroenterology 2016;150(1):64-78. 23 Bagheri V, Memar B, Momtazi AA, et al. Cytokine networks and their association with Helicobacter pylori infection in gastric carcinoma. J Cell Physiol 2017. 24 Harrington LE, Hatton RD, Mangan PR, et al. Interleukin 17-producing CD4+ effector T cells develop via a lineage distinct from the T helper type 1 and 2 lineages. Nat Immunol 2005;6(11):1123-32. 25 Malaty HM, Engstrand L, Pedersen NL, et al. Helicobacter pylori infection: genetic and environmental influences. A study of twins. Ann Intern Med 1994;120(12):982-6. 26 El-Omar EM, Carrington M, Chow WH, et al. Interleukin-1 polymorphisms associated with increased risk of gastric cancer. Nature 2000;404(6776):398-402. 27 Machado JC, Pharoah P, Sousa S, et al. Interleukin 1B and interleukin 1RN polymorphisms are associated with increased risk of gastric carcinoma. Gastroenterology 2001;121(4):823-9. 28 Machado JC, Figueiredo C, Canedo P, et al. A proinflammatory genetic profile increases the risk for chronic atrophic gastritis and gastric carcinoma. Gastroenterology 2003;125(2):364-71. 29 Chen YL, Mo XQ, Huang GR, et al. Gene polymorphisms of pathogenic Helicobacter pylori in patients with different types of gastrointestinal diseases. World J Gastroenterol 2016;22(44):9718-26. 30 Tanikawa C, Urabe Y, Matsuo K, et al. A genome-wide association study identifies two susceptibility loci for duodenal ulcer in the Japanese population. Nat Genet 2012;44(4):430-4, S1-2. 31 Hofner P, Gyulai Z, Kiss ZF, et al. Genetic polymorphisms of NOD1 and IL-8, but not polymorphisms of TLR4 genes, are associated with Helicobacter pylori-induced duodenal ulcer and gastritis. Helicobacter 2007;12(2):124-31. 32 Figueiredo CA, Marques CR, Costa Rdos S, et al. Cytokines, cytokine gene polymorphisms and Helicobacter pylori infection: friend or foe? World J Gastroenterol 2014;20(18):5235-43. 33 Boren T, Falk P, Roth KA, et al. Attachment of Helicobacter pylori to human gastric epithelium mediated by blood group antigens. Science 1993;262(5141):1892-5. 34 Ilver D, Arnqvist A, Ogren J, et al. Helicobacter pylori adhesin binding fucosylated histo-blood group antigens revealed by retagging. Science 1998;279(5349):373-7. 35 Magnusson PKE, Enroth H, Eriksson I, et al. Gastric cancer and human leukocyte antigen: distinct DQ and DR alleles are associated with development of gastric cancer and infection by Helicobacter pylori. Cancer Res 2001;61(6):2684-9. 36 Hartland S, Newton JL, Griffin SM, et al. A functional polymorphism in the interleukin-1 receptor-1 gene is associated with increased risk of Helicobacter pylori infection but not with gastric cancer. Dig Dis Sci 2004;49(9):1545-50. 37 Mayerle J, den Hoed CM, Schurmann C, et al. Identification of genetic loci associated with Helicobacter pylori serologic status. JAMA 2013;309(18):1912-20. 38 Barabino A. Helicobacter pylori-related iron deficiency anemia: a review. Helicobacter 2002;7(2):71-5. 39 Malfertheiner P, Megraud F, O'Morain C, et al. Current concepts in the management of Helicobacter pylori infection: the Maastricht III Consensus Report. Gut 2007;56(6):772-81. 40 Koletzko S, Jones NL, Goodman KJ, et al. Evidence-based guidelines from ESPGHAN and NASPGHAN for Helicobacter pylori infection in children. J Pediatr Gastroenterol Nutr 2011;53(2):230-43. 41 Angeles Vazquez Lopez M, Molinos FL, Carmona ML, et al. Serum transferrin receptor in children: usefulness for determinating the nature of anemia in infection. J Pediatr Hematol Oncol 2006;28(12):809-15. 42 Tsai KF, Liou JM, Chen MJ, et al. Distinct Clinicopathological Features and Prognosis of Helicobacter pylori Negative Gastric Cancer. PLoS One 2017;12(2):e0170942. 43 Chen ST, Su YN, Ni YH, et al. Diagnosis of neonatal intrahepatic cholestasis caused by citrin deficiency using high-resolution melting analysis and a clinical scoring system. J Pediatr 2012;161(4):626-31. 44 Tseng FC, Brown EE, Maiese EM, et al. Polymorphisms in cytokine genes and risk of Helicobacter pylori infection among Jamaican children. Helicobacter 2006;11(5):425-30. 45 Wu MS, Wu CY, Chen CJ, et al. Interleukin-10 genotypes associate with the risk of gastric carcinoma in Taiwanese Chinese. Int J Cancer 2003;104(5):617-23. 46 Lu W, Pan K, Zhang L, et al. Genetic polymorphisms of interleukin (IL)-1B, IL-1RN, IL-8, IL-10 and tumor necrosis factor {alpha} and risk of gastric cancer in a Chinese population. Carcinogenesis 2005;26(3):631-6. 47 Waghray M, Zavros Y, Saqui-Salces M, et al. Interleukin-1beta promotes gastric atrophy through suppression of Sonic Hedgehog. Gastroenterology 2010;138(2):562-72, 72 e1-2. 48 Wolfe MM, Nompleggi DJ. Cytokine inhibition of gastric acid secretion--a little goes a long way. Gastroenterology 1992;102(6):2177-8. 49 Hwang IR, Kodama T, Kikuchi S, et al. Effect of interleukin 1 polymorphisms on gastric mucosal interleukin 1beta production in Helicobacter pylori infection. Gastroenterology 2002;123(6):1793-803. 50 Queiroz DM, Harris PR, Sanderson IR, et al. Iron status and Helicobacter pylori infection in symptomatic children: an international multi-centered study. PLoS One 2013;8(7):e68833. 51 Serrano CA, Villagran A, Toledo H, et al. Iron Deficiency and IL1beta Polymorphisms in Helicobacter pylori-infected Children. Helicobacter 2016;21(2):124-30. 52 Mentis A, Blackwell CC, Weir DM, et al. ABO blood group, secretor status and detection of Helicobacter pylori among patients with gastric or duodenal ulcers. Epidemiol Infect 1991;106(2):221-9. 53 Wu TC, Chen LK, Hwang SJ. Seroprevalence of Helicobacter pylori in school-aged Chinese in Taipei City and relationship between ABO blood groups. World J Gastroenterol 2003;9(8):1752-5. 54 Yamamoto F, Clausen H, White T, et al. Molecular genetic basis of the histo-blood group ABO system. Nature 1990;345(6272):229-33. 55 Amundadottir L, Kraft P, Stolzenberg-Solomon RZ, et al. Genome-wide association study identifies variants in the ABO locus associated with susceptibility to pancreatic cancer. Nat Genet 2009;41(9):986-90. 56 Rummel S, Shriver CD, Ellsworth RE. Relationships between the ABO blood group SNP rs505922 and breast cancer phenotypes: a genotype-phenotype correlation study. BMC Med Genet 2012;13:41. 57 Melzer D, Perry JR, Hernandez D, et al. A genome-wide association study identifies protein quantitative trait loci (pQTLs). PLoS Genet 2008;4(5):e1000072. 58 Pare G, Chasman DI, Kellogg M, et al. Novel association of ABO histo-blood group antigen with soluble ICAM-1: results of a genome-wide association study of 6,578 women. PLoS Genet 2008;4(7):e1000118. 59 Suzuki H, Franceschi F, Nishizawa T, et al. Extragastric manifestations of Helicobacter pylori infection. Helicobacter 2011;16 Suppl 1(65-9. 60 Nakao K, Imoto I, Gabazza EC, et al. Gastric juice levels of lactoferrin and Helicobacter pylori infection. Scand J Gastroenterol 1997;32(6):530-4. 61 Nakao K, Imoto I, Ikemura N, et al. Relation of lactoferrin levels in gastric mucosa with Helicobacter pylori infection and with the degree of gastric inflammation. Am J Gastroenterol 1997;92(6):1005-11. 62 Hentze MW, Muckenthaler MU, Galy B, et al. Two to tango: regulation of Mammalian iron metabolism. Cell 2010;142(1):24-38. 63 Robens J. Hepcidin: the link to understanding iron regulation. MLO Med Lab Obs 2010;42(10):10, 12, 14; quiz 18-9. 64 Ganz T, Nemeth E. Hepcidin and iron homeostasis. Biochim Biophys Acta 2012;1823(9):1434-43. 65 Weiss G. Iron metabolism in the anemia of chronic disease. Biochim Biophys Acta 2009;1790(7):682-93. 66 Queiroz DM, Rocha AM, Melo FF, et al. Increased gastric IL-1beta concentration and iron deficiency parameters in H. pylori infected children. PLoS One 2013;8(2):e57420. 67 Emiralioglu N, Yenicesu I, Sari S, et al. An insight into the relationships between prohepcidin, iron deficiency anemia, and interleukin-6 values in pediatric Helicobacter pylori gastritis. Eur J Pediatr 2015;174(7):903-10. 68 Schwarz P, Kubler JA, Strnad P, et al. Hepcidin is localised in gastric parietal cells, regulates acid secretion and is induced by Helicobacter pylori infection. Gut 2012;61(2):193-201. 69 Chen ST, Ni YH, Liu SH. Potential association of IL1B polymorphism with iron deficiency risk in childhood Helicobacter pylori infection. J Pediatr Gastroenterol Nutr 2017;66(2):e36-e40. 70 Osterholm EA, Georgieff MK. Chronic inflammation and iron metabolism. J Pediatr 2015;166(6):1351-7. 71 DuBois S, Kearney DJ. Iron-deficiency anemia and Helicobacter pylori infection: a review of the evidence. Am J Gastroenterol 2005;100(2):453-9. 72 Huang YH, Kuo HC, Huang FC, et al. Hepcidin-induced iron deficiency is related to transient anemia and hypoferremia in Kawasaki disease patients. Int J Mol Sci 2016;17(5). 73 Lin YF, Wu MS, Chang CC, et al. Comparative immunoproteomics of identification and characterization of virulence factors from Helicobacter pylori related to gastric cancer. Mol Cell Proteomics 2006;5(8):1484-96. 74 Choi HS, Song SH, Lee JH, et al. Serum hepcidin levels and iron parameters in children with iron deficiency. Korean J Hematol 2012;47(4):286-92. 75 Lee SY, Song EY, Yun YM, et al. Serum prohepcidin levels in Helicobacter pylori infected patients with iron deficiency anemia. Korean J Intern Med 2010;25(2):195-200. 76 Azab SF, Esh AM. Serum hepcidin levels in Helicobacter pylori-infected children with iron-deficiency anemia: a case-control study. Ann Hematol 2013;92(11):1477-83. 77 Ozkasap S, Yarali N, Isik P, et al. The role of prohepcidin in anemia due to Helicobacter pylori infection. Pediatr Hematol Oncol 2013;30(5):425-31. 78 Sasu BJ, Li H, Rose MJ, et al. Serum hepcidin but not prohepcidin may be an effective marker for anemia of inflammation (AI). Blood Cells Mol Dis 2010;45(3):238-45. 79 Cherian S, Forbes DA, Cook AG, et al. An insight into the relationships between hepcidin, anemia, infections and inflammatory cytokines in pediatric refugees: a cross-sectional study. PLoS One 2008;3(12):e4030. 80 Takashima M, Furuta T, Hanai H, et al. Effects of Helicobacter pylori infection on gastric acid secretion and serum gastrin levels in Mongolian gerbils. Gut 2001;48(6):765-73. 81 Khaiboullina SF, Abdulkhakov S, Khalikova A, et al. Serum Cytokine Signature That Discriminates Helicobacter pylori Positive and Negative Juvenile Gastroduodenitis. Front Microbiol 2016;7(1916. 82 Harris PR, Wright SW, Serrano C, et al. Helicobacter pylori gastritis in children is associated with a regulatory T-cell response. Gastroenterology 2008;134(2):491-9. 83 Jacob M, Lopata AL, Dasouki M, et al. Metabolomics toward personalized medicine. Mass Spectrom Rev 2017. 84 Wishart DS, Jewison T, Guo AC, et al. HMDB 3.0--the human metabolome database in 2013. Nucleic Acids Res 2013;41(Database issue):D801-7. 85 Wu RQ, Zhao XF, Wang ZY, et al. Novel molecular events in oral carcinogenesis via integrative approaches. J Dent Res 2011;90(5):561-72. 86 Beger RD. A review of applications of metabolomics in cancer. Metabolites 2013;3(3):552-74. 87 Blekherman G, Laubenbacher R, Cortes DF, et al. Bioinformatics tools for cancer metabolomics. Metabolomics 2011;7(3):329-43. 88 Khatri P, Sirota M, Butte AJ. Ten years of pathway analysis: current approaches and outstanding challenges. PLoS Comput Biol 2012;8(2):e1002375. 89 Nazari P, Dowlatabadi-Bazaz R, Mofid MR, et al. The antimicrobial effects and metabolomic footprinting of carboxyl-capped bismuth nanoparticles against Helicobacter pylori. Appl Biochem Biotechnol 2014;172(2):570-9. 90 Kuo CH, Lee CW, Lin SC, et al. Rapid determination of aristolochic acids I and II in herbal products and biological samples by ultra-high-pressure liquid chromatography-tandem mass spectrometry. Talanta 2010;80(5):1672-80. 91 Chen HH, Tseng YJ, Wang SY, et al. The metabolome profiling and pathway analysis in metabolic healthy and abnormal obesity. Int J Obes (Lond) 2015;39(8):1241-8. 92 Ho TJ, Kuo CH, Wang SY, et al. True ion pick (TIPick): a denoising and peak picking algorithm to extract ion signals from liquid chromatography/mass spectrometry data. J Mass Spectrom 2013;48(2):234-42. 93 Xia J, Wishart DS. MetPA: a web-based metabolomics tool for pathway analysis and visualization. Bioinformatics 2010;26(18):2342-4. 94 Tome D, Bos C. Lysine requirement through the human life cycle. J Nutr 2007;137(6 Suppl 2):1642S-1645S. 95 Citak EC, Citak FE, Kurekci AE. Serum carnitine levels in children with iron-deficiency anemia with or without pica. Pediatr Hematol Oncol 2006;23(5):381-5. 96 Schwab MA, Sauer SW, Okun JG, et al. Secondary mitochondrial dysfunction in propionic aciduria: a pathogenic role for endogenous mitochondrial toxins. Biochem J 2006;398(1):107-12. | |
dc.identifier.uri | http://tdr.lib.ntu.edu.tw/jspui/handle/123456789/69926 | - |
dc.description.abstract | 幽門螺旋桿菌感染主要發生於兒童時期且可能造成嚴重的鐵質缺乏或缺鐵性貧血,然而並非所有幽門桿菌感染的兒童全都會造成鐵質缺乏。為了解幽門桿菌感染兒童導致鐵質缺乏的相關宿主因素,我們進行一系列研究,納入幽門桿菌感染兒童及對照兒童,比較可能導致鐵質缺乏相關的宿主因素。第一部分,為探討宿主基因易感性,我們在雲林縣進行了幽門桿菌流行病學調查,從一般族群納入644位10至18歲兒童,依血清抗體結果分為2組,分別檢測5個宿主基因多型性,包含IL1B (rs1143627 and rs16944)、IL8 (rs4073)、IL10 (rs1800896)及ABO (rs505922),並比較血中鐵的程度。本研究中使用的鐵質缺乏定義為鐵飽和度小於15百分比。結果顯示在多變數分析下,抗體陽性兒童相較抗體陰性兒童,顯著帶有較高比率之rs505922基因型T allele (OR = 6.128; P < 0.001)及rs1143627基因型T allele (OR = 0.846; P = 0.014)。在59位抗體陽性兒童中,鐵質缺乏兒童相較無鐵質缺乏兒童,顯著帶有較高比率之rs1143627基因型T allele (OR = 3.156; P = 0.043)。本研究顯示ABO 基因多型性rs505922及 IL1B 基因多型性rs1143627可能影響幽門桿菌感染之易感性,且IL1B 基因多型性rs1143627也可能影響感染後鐵質缺乏之風險。第二部份,針對探討宿主血清鐵調素、血清細胞激素濃度及鐵質缺乏於幽門桿菌感染之關聯,我們納入86位兒童(43位幽門桿菌抗體陽性,43位抗體陰性),檢測血液內鐵質程度、血清細胞激素IL-1β、IL-6、IL-8濃度,及鐵調素濃度,其中幽門桿菌抗體陽性兒童分為低鐵調素組(共22人)與高鐵調素組(共21人)做比較。結果發現血清細胞激素IL-1β、IL-6濃度在抗體陽性與抗體陰性兒童間並無不同,血清鐵調素濃度亦然(濃度為6.5 ng/mL及8.6 ng/mL; P = 0.1318)。於抗體陽性兒童中,低鐵調素組相較高鐵調素組,其血中鐵質、鐵蛋白及總鐵結合能均顯著較低(P = 0.0123, P = 0.0001及P = 0.0004),且具有較高比率之鐵質缺乏 (33.3%比4.5%; P = 0.015)。同時,低鐵調素組其血清細胞激素IL-1β及IL-6濃度亦顯著較低(P = 0.0151及P = 0.0015),IL-8則無顯著差異。研究結果顯示發炎反應之細胞激素IL-1β及IL-6可能與幽門桿菌抗體陽性兒童之高鐵調素相關。血清鐵調素組下降可能是幽門桿菌感染相關鐵質缺乏之負回饋抑制的結果,而非導致鐵質缺乏的原因。第三部分,為探討幽門桿菌相關鐵質缺乏兒童血清代謝物的差異,我們納入35位幽門桿菌抗體陽性兒童,其中鐵質缺乏17位,無鐵質缺乏18位。運用液相層析質譜儀方法,分析比較血清代謝體差異。經由代謝路徑分析發現,鐵質缺乏兒童相較無鐵質缺乏兒童,最顯著改變的代謝路徑為離胺酸降解路徑、丙酸代謝路徑、纈胺酸/異白胺酸/白胺酸降解路徑、菸鹼酸/菸鹼胺降解路徑,及酪胺酸代謝路徑。綜合而言,本研究探討了許多可能影響兒童幽門桿菌相關鐵質缺乏之宿主因素。未來仍需更多研究驗證宿主因素在幽門桿菌感染的重要性。 | zh_TW |
dc.description.abstract | Helicobacter pylori (H. pylori) infection occurs predominantly in childhood and could results in severe iron deficiency (ID) or iron deficiency anemia (IDA). However, not all H. pylori-infected patients exhibit iron deficiency. To understand the host factors related to the occurrence of ID among H. pylori-infected children, we conducted a pediatric study of H. pylori-infected children and controls and analyzed the differential factors regarding to the H. pylori-induced ID. First, to investigate the host susceptibility, we conducted a seroprevalence study of H. pylori infection in Yun-Lin County. Subjects (n = 644) from the general population aged 10 to 18 years were divided into two groups based on serology testing for anti-H. pylori IgG. Five single nucleotide polymorphisms (SNPs) in IL1B (rs1143627 and rs16944), IL8 (rs4073), IL10 (rs1800896), and ABO (rs505922), were genotyped and the iron status of the two groups was compared. ID is defined as iron saturation less than 15%. The results showed, in multivariate analysis, significantly higher frequency of the T allele of rs505922 (OR = 6.128; P < 0.001) and lower frequency of the T allele of rs1143627 (OR = 0.846; P = 0.014) in seropositive versus seronegative subjects. Among 59 seropositive subjects, the T allele frequency of rs1143627 was significantly higher in those with iron deficiency (OR = 3.156; P = 0.043), compared to those without iron deficiency. ABO (rs505922) and IL1B (rs1143627) may affect H. pylori infection susceptibility, and IL1B (rs1143627) may also influence iron deficiency risk in infected children. Secondly, to clarify relationship between serum hepcidin, cytokine levels and ID in H. pylori infected children, we enrolled 86 participants (43 seropositive and 43 seronegative) based on the anti-H. pylori IgG status. Serum hepcidin levels, iron profiles, and serum cytokines (IL-1β, IL-6, and IL-8) levels were measured. Seropositive children were divided into low hepcidin (n = 22) and high hepcidin (n = 21) groups. The results showed that serum IL-1β and IL-6 levels were comparable between H. pylori seropositive and seronegative children, as were the median serum hepcidin levels (6.5 ng/mL versus 8.6 ng/mL; P = 0.1318). Median levels of serum iron, ferritin, and iron saturation were significantly lower in seropositive children with low hepcidin than in those with high hepcidin (P = 0.0123, P = 0.0001, and P = 0.0004, respectively), as well as in those with a significantly higher prevalence of ID (33.3% versus 4.5%; P = 0.015). Compared to the high hepcidin seropositive group, the low hepcidin group had significantly lower median serum levels of cytokines IL-1β and IL-6, but not IL-8 (P = 0.0151 and P = 0.0015, respectively). Inflammatory cytokines IL-1β and IL-6, but not IL-8, might be associated with increased hepcidin levels among H. pylori seropositive children. Low serum hepcidin might be the result of feedback inhibition rather than the cause of ID in children with H. pylori–induced ID. Last, to analyze the differences of serum metabolites related to H. pylori–induced ID, we enrolled 35 H. pylori seropositive children with (n = 17) and without ID (n = 18). Using liquid chromatography mass spectrometry (LC-MS), the serum metabolites were analyzed and compared between children with and without ID. After metabolomic pathway analysis, the main altered pathways among H. pylori seropositive children with ID versus without ID were the lysine degradation, propanoate metabolism pathway, valine, leucine, and isoleucine degradation pathway, nicotinate and nicotinamide degradation pathway, and tyrosine metabolism pathway. Taken together, our studies demonstrated various host factors related to H. pylori–induced ID in children. More studies are warranted to clarify the significance of host factors H. pylori in infection. | en |
dc.description.provenance | Made available in DSpace on 2021-06-17T03:34:26Z (GMT). No. of bitstreams: 1 ntu-107-D02447003-1.pdf: 7124972 bytes, checksum: a68c55fef81dfe8fd1297e73bdf847fe (MD5) Previous issue date: 2018 | en |
dc.description.tableofcontents | 口試委員會審定書 i
誌謝 ii 中文摘要 iii ABSTRACT v CONTENTS vii LIST OF FIGURES ix LIST OF TABLES x Chapter 0 General Overview 1 Chapter 1 Host Genetic Susceptibility 4 1.1 Introduction 4 1.2 Materials and Methods 10 1.3 Results 14 1.4 Discussion 17 1.5 Conclusions 21 1.6 Tables 22 Chapter 2 Serum Cytokines, Hepcidin, and Iron Deficiency 27 2.1 Introduction 27 2.2 Materials and Methods 32 2.3 Results 35 2.4 Discussion 38 2.5 Conclusions 42 2.6 Tables 43 2.7 Figures and Figure Legends 46 Chapter 3 Metabolomics Analysis 49 3.1 Introduction 49 3.2 Materials and Methods 54 3.3 Results 58 3.4 Discussion 60 3.5 Conclusions 62 3.6 Tables 63 3.7 Figures and Figure Legends 65 FUTURE PERSPECTIVE 72 REFERENCES 73 APPENDIX 81 | |
dc.language.iso | en | |
dc.title | 兒童幽門桿菌相關鐵質缺乏機制: 宿主因素探討 | zh_TW |
dc.title | The Mechanism of Helicobacter pylori-related Iron Deficiency in Children: Focus on Host Factors | en |
dc.type | Thesis | |
dc.date.schoolyear | 106-1 | |
dc.description.degree | 博士 | |
dc.contributor.coadvisor | 倪衍玄(Yen-Hsuan Ni) | |
dc.contributor.oralexamcommittee | 姜至剛(Chih-Kang Chiang),李建璋(Chien-Chang Lee),楊榮森(Rong-Sen Yang) | |
dc.subject.keyword | 幽門螺旋桿菌,鐵質缺乏,宿主基因多型性,細胞激素,鐵調素,代謝體, | zh_TW |
dc.subject.keyword | H. pylori,iron deficiency,susceptibility,cytokines,hepcidin,metabolomics, | en |
dc.relation.page | 82 | |
dc.identifier.doi | 10.6342/NTU201800555 | |
dc.rights.note | 有償授權 | |
dc.date.accepted | 2018-02-13 | |
dc.contributor.author-college | 醫學院 | zh_TW |
dc.contributor.author-dept | 毒理學研究所 | zh_TW |
顯示於系所單位: | 毒理學研究所 |
文件中的檔案:
檔案 | 大小 | 格式 | |
---|---|---|---|
ntu-107-1.pdf 目前未授權公開取用 | 6.96 MB | Adobe PDF |
系統中的文件,除了特別指名其著作權條款之外,均受到著作權保護,並且保留所有的權利。